Paradigm Biocapital Advisors LP 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Kura Oncology, Inc. KURA | Paradigm Biocapital Advisors LP | 4,331,321 5.700% | 470,003 (+12.17%) | Filing |
| 2024-05-02 4:34 pm Purchase | 2024-04-22 | 13G | Kura Oncology, Inc. KURA | Paradigm Biocapital Advisors LP | 3,861,318 5.100% | 3,861,318 (New Position) | Filing |